This review discusses the treatment of primary, nonmetastatic HER2-positive breast cancer in the adjuvant and neoadjuvant settings-settings in which tremendous progress has been made.
Zoneddy Dayao, MD
Advertisement
Articles by Zoneddy Dayao, MD
Advertisement
Latest Updated Articles
HER2-Targeted Therapy for Early-Stage Breast Cancer: A Comprehensive ReviewPublished: April 15th 2014 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Could Scorpion Venom Component Play a Role in Glioblastoma Management?
2
How Dato-DXd and the TROPION Trials Are Transforming Solid Tumor Research
3
Evaluating the Viability of Antibody Drug Conjugates for Glioblastoma
4
What Were The Most Impactful GU Oncology Data From ESMO 2025?
5
